Menu

  • Medtronic Academy

    • What is Ventilator-Associated Pneumonia (VAP)?

    Pneumonia is defined as Ventilator-Associated Pneumonia (VAP) if an invasive respiratory device was present (even intermittently) in the 48 hours preceding the onset of infection.1,2

    Patients who require invasive mechanical ventilation are at risk for ventilator-associated pneumonia (VAP).

    Ventilator-Associated Pneumonia (VAP) is the most common and deadly ICU nosocomial infection.1-3

    The most common cause of ventilator-associated pneumonia is microaspiration of bacteria that colonize the oropharynx and upper airways in seriously ill patients4, and it presents with clinical signs that include purulent tracheal discharge, fevers, and respiratory distress in the presence of microorganisms.5

    The clinical and economic impact of
    Ventilator-Associated Pneumonia

    Lifesaver ring blue icon

    Up to 51% of direct mortality1,3,6-8

    Blue icon of a calendar with one day marked

    Up to 16 extra days on mechanical ventilation9,10

    Blue hospital icon

    Up to 20 extra days in the intensive care unit9-13

    Blue euro currency icon

    Up to €42.300 extra cost per VAP episode11,13-15

    Our integrated solutions contribute to Ventilator-Associated Pneumonia reduction

    ICU Solutions for VAP

    Our integrated solutions aim to:

    • Enhance preventive bundle compliance
    • Improve patient experience and outcomes
    • Assist you with daily patient management
    • Improve the quality of care
    Request a free demo (open in new window)

    Product technologies for Ventilator Associated Pneumonia prevention

    Lifesaver ring blue icon

    Shiley™ tracheostomy tube for VAP prevention

    Continous pressure control in tapered cuff endotracheal tube (ETT) with continous automatic subglottic secretion suction can reduce the total incidence of Ventilator-Associated Pneumonia (VAP) up to 50%, as well as increase the time to Ventilator-Associated Pneumonia (VAP) in mechanically ventilated ICU patients.16 Subglottic secretion drainage reduces the incidence of VAP in critically ill patiens requiring ongoing mechanical ventilation via tracheostomy.18

    Flexible adult evac tracheostomy tubes with TaperGuard™ cuff technology

    • Integrated evac lumen enables removal of secretions from subglottic spaces
    • Designed with a slightly larger outer diameter to support the evac lumen for secretion removal
    • Available in single cannula, reusable inner cannula and disposable inner cannula configurations
    Blue icon of a calendar with one day marked

    Evac oral endotracheal tube with TaperGuard™ cuff technology

    Shiley™ evac technology


    Subglottic secretion drainage (SSD) helps remove oral and/or gastric secretions from above the endotracheal tube cuff before they can be aspirated.22

     

    TaperGuard™ cuff technology 


    The tapered-shape cuff allows for uniform pressure distribution to maintain an adequate seal thereby reducing the risk of microaspiration.21

    Subglottic secretion drainage (SSD) was found to be an effective measure to prevent VAP with (44% risk reduction).17

    Lifesaver ring blue icon

    Hersill VACUSILL® 3 for VAP

    Subglottic automatic suction system

    Traditional versus automatic secretions drainage: 

     

    Direct wall suction

    • Cannot be regulated - Risk of high pressure (4x > recommended) or too low to aspirate
    • Risk of cross-infection (37% of regulators colonized)19
    • No filter to prevent backlog

    Syringe suction

    • Pressure 4-5x higher (-580 to -720 mmHg) than recommended (<-150mmHg)
    • Limited volume of secretions collected19

    Automatic pump

    • Optimized to recommended pressure 
    • Optimal On/Off cycle to maximize secretion collection while minimizing injury the tracheal mucosa19
    • Collect up to 10x more secretions daily than other modalities19 
    • Significantly reduce cross-contamination through use of an integrated, self-contained, disposable canister and filter

    When technology, driven by evidence-based research, is fully engaged, it can be used to design andengineer the breakthrough devices that will improve, optimize and change the way we administer proven therapies.19

    Blue icon of a calendar with one day marked

    Puritan Bennett™ for VAP

    Cuff pressure manager

    Offers a simple solution to a serious safety issue by continuously measuring and automatically maintaining cuff pressure of the ventilated patients:

    • Reduces manual work of measuring and adjusting cuff pressure with a manometer and syringe20,23,24
    • Provides uninterrupted monitoring and management 
    • Improves adherence to established cuff pressure protocols25

    It's designed to support cuffed endotracheal tubes or cuffed tracheostomy tubes for adult and pediatric patients in the following sizes:

    Cuffed endotracheal tubes:

    Sizes 3 - 10 (inner diameter)

    Cuffed tracheostomy tubes:

    Sizes 2.5 - 10 (inner diameter of outer cannula)

    Continuous control of cuff was associated with significantly reduced incidence of VAP (53% risk reduction).20

    With our Ventilator-Associated Pneumonia (VAP) integrated solutions, we aim to:

    Contribute

    to prevent patient complications and alleviate relatives' emotional distress.

     

    Facilitate

    the work of the healthcare professionals and improve the quality of the care provided.

     

    Cooperate

    to reduce VAP incidence and hospital's direct costs.

    Improve patient experience and outcomes

    Interested in a free demo of our Ventilator-Associated Pneumonia (VAP) integrated solutions?

    Book now (open in new window)